ClearPoint Neuro, Inc.
CLPT
$9.42
-$0.09-0.95%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 33.96% | 9.10% | 17.27% | 11.07% | 14.11% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 33.96% | 9.10% | 17.27% | 11.07% | 14.11% |
| Cost of Revenue | 33.13% | -0.43% | 27.49% | 7.68% | 7.58% |
| Gross Profit | 34.48% | 15.54% | 11.39% | 13.41% | 18.66% |
| SG&A Expenses | 19.05% | 10.97% | 12.36% | 29.43% | 16.47% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.77% | 6.45% | 18.38% | 23.56% | 16.42% |
| Operating Income | 6.94% | -2.29% | -20.24% | -46.18% | -19.76% |
| Income Before Tax | -43.63% | -18.61% | -32.30% | -45.44% | -17.30% |
| Income Tax Expenses | 112.50% | -42.86% | 66.67% | 20.00% | -- |
| Earnings from Continuing Operations | -44.56% | -18.44% | -32.42% | -45.34% | -16.61% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -44.56% | -18.44% | -32.42% | -45.34% | -16.61% |
| EBIT | 6.94% | -2.29% | -20.24% | -46.18% | -19.76% |
| EBITDA | 8.69% | -6.46% | -17.66% | -52.53% | -19.30% |
| EPS Basic | -38.27% | -14.92% | -28.72% | -33.46% | -4.05% |
| Normalized Basic EPS | -5.62% | -15.04% | -28.50% | -33.63% | -4.69% |
| EPS Diluted | -38.27% | -14.92% | -28.72% | -33.46% | -4.05% |
| Normalized Diluted EPS | -5.62% | -15.04% | -28.50% | -33.63% | -4.69% |
| Average Basic Shares Outstanding | 4.56% | 3.03% | 2.88% | 8.91% | 12.05% |
| Average Diluted Shares Outstanding | 4.56% | 3.03% | 2.88% | 8.91% | 12.05% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |